Cargando…

Genetic contribution and associated pathophysiology in end-stage renal disease

End-stage renal disease (ESRD) or chronic kidney disease (CKD) is the terminal state of the kidney when its function has been permanently and irreversibly damaged. A wide variety of etiologies and pathological processes culminate in ESRD, and both environmental and genetic factors contribute to its...

Descripción completa

Detalles Bibliográficos
Autores principales: Agrawal, Suraksha, Agarwal, SS, Naik, Sita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681165/
https://www.ncbi.nlm.nih.gov/pubmed/23776353
_version_ 1782273214731255808
author Agrawal, Suraksha
Agarwal, SS
Naik, Sita
author_facet Agrawal, Suraksha
Agarwal, SS
Naik, Sita
author_sort Agrawal, Suraksha
collection PubMed
description End-stage renal disease (ESRD) or chronic kidney disease (CKD) is the terminal state of the kidney when its function has been permanently and irreversibly damaged. A wide variety of etiologies and pathological processes culminate in ESRD, and both environmental and genetic factors contribute to its development and progression. Various reports suggest that susceptibility to develop ESRD has a significant genetic component. These studies include familial aggregation studies, comparisons of incidence rates between different racial or ethnic populations, and segregation analysis. Genetic approaches have been used to identify genes that contribute to genetic susceptibility. Many studies have now been carried out assessing the contribution of specific “candidate genes”, which correlate with different functions that are involved in the renal pathogenesis. Independent studies for specific associated genes have frequently provided contradictory results. This may be due, in part, to the modest contribution to genetic susceptibility which these genes impart. With the availability of different genomewide association studies, chromosomal regions harboring novel, previously unrecognized, genes that may contribute to renal diseases have been recently reported. We have focused on different genetic studies conducted on ESRD and have discussed the strength and weaknesses of these studies. The nonmuscle myosin heavy chain 9 gene (MYH9) and renin–angiotensin system (RAS) have been discussed in detail.
format Online
Article
Text
id pubmed-3681165
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-36811652013-06-17 Genetic contribution and associated pathophysiology in end-stage renal disease Agrawal, Suraksha Agarwal, SS Naik, Sita Appl Clin Genet Review End-stage renal disease (ESRD) or chronic kidney disease (CKD) is the terminal state of the kidney when its function has been permanently and irreversibly damaged. A wide variety of etiologies and pathological processes culminate in ESRD, and both environmental and genetic factors contribute to its development and progression. Various reports suggest that susceptibility to develop ESRD has a significant genetic component. These studies include familial aggregation studies, comparisons of incidence rates between different racial or ethnic populations, and segregation analysis. Genetic approaches have been used to identify genes that contribute to genetic susceptibility. Many studies have now been carried out assessing the contribution of specific “candidate genes”, which correlate with different functions that are involved in the renal pathogenesis. Independent studies for specific associated genes have frequently provided contradictory results. This may be due, in part, to the modest contribution to genetic susceptibility which these genes impart. With the availability of different genomewide association studies, chromosomal regions harboring novel, previously unrecognized, genes that may contribute to renal diseases have been recently reported. We have focused on different genetic studies conducted on ESRD and have discussed the strength and weaknesses of these studies. The nonmuscle myosin heavy chain 9 gene (MYH9) and renin–angiotensin system (RAS) have been discussed in detail. Dove Medical Press 2010-08-05 /pmc/articles/PMC3681165/ /pubmed/23776353 Text en © 2010 Agrawal et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Agrawal, Suraksha
Agarwal, SS
Naik, Sita
Genetic contribution and associated pathophysiology in end-stage renal disease
title Genetic contribution and associated pathophysiology in end-stage renal disease
title_full Genetic contribution and associated pathophysiology in end-stage renal disease
title_fullStr Genetic contribution and associated pathophysiology in end-stage renal disease
title_full_unstemmed Genetic contribution and associated pathophysiology in end-stage renal disease
title_short Genetic contribution and associated pathophysiology in end-stage renal disease
title_sort genetic contribution and associated pathophysiology in end-stage renal disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681165/
https://www.ncbi.nlm.nih.gov/pubmed/23776353
work_keys_str_mv AT agrawalsuraksha geneticcontributionandassociatedpathophysiologyinendstagerenaldisease
AT agarwalss geneticcontributionandassociatedpathophysiologyinendstagerenaldisease
AT naiksita geneticcontributionandassociatedpathophysiologyinendstagerenaldisease